Roche Holding (RHHBY)
(Delayed Data from OTC)
$38.54 USD
+0.34 (0.89%)
Updated Jul 24, 2024 03:59 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Brokerage Reports
0 items in cart
Roche Holding AG [RHHBY]
Reports for Purchase
Showing records 41 - 60 ( 161 total )
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Biopharma''s Next $100B-Plus Global Market: Cures for Chronic Hepatitis B Virus Infection
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Roche Holding AG
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department